JNJ-64042056 clinical trials

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

This study is testing a new medicine, JNJ-64042056, for people who are at very early stages of Alzheimer's disease. Researchers want to see if the medicine can stop a specific brain protein, called tau, from building up and spreading, which is linked to the condition.